Venus Concept shares rise 10.24% intraday as short interest drops 19.6% on September 16.

think> Okay, let's tackle this query. The user provided Venus Concept's stock performance: it went up 10.23622047% intraday. The task is to link this movement to relevant news events. First, I need to check the recent news events listed. There are several, but I need to see which ones are recent and relevant. The stock movement is intraday, so the news should have been released around that time. Let's go through the news. The latest news on September 23 mentions a "Head-To-Head Contrast: Presbia vs Venus Concept" from americanbankingnews.com. But the summary doesn't provide much detail. Another recent news from September 16 says short interest dropped by 19.6%. Short interest decreasing can be bullish as it indicates less bearish sentiment. The September 14 news mentions 510(k) clearance for the Venus Versa Pro system, which is a regulatory approval, positive for the company. Then there's a September 6 news about presenting at a conference. Looking at the percentages, the 10.23% increase is significant. The 510(k) clearance on September 14 is a positive event. However, if the stock moved intraday on the 23rd, the most recent news before that would be the short interest drop on the 16th. But the 510(k) clearance is a major product-related approval, which could drive investor confidence. Also, the Head-To-Head article might have highlighted positive comparisons, but without more info, it's hard to say. Wait, the user's example shows that the relevant news is the one directly causing the movement. The 510(k) clearance is a regulatory milestone, which is a positive catalyst. The drop in short interest on the 16th is also positive. However, the stock movement is intraday on the 23rd. The 510(k) was on the 14th, which is a week before. If there's no more recent news, maybe the drop in short interest on the 16th is the driver. But the 10.23% jump is quite large, so a regulatory approval might be the key. Wait, the 510(k) clearance is for the Venus Versa Pro system, a multi-application platform. That's a product launch, which could boost investor confidence. If the stock is reacting to that approval, even if it's a week old, maybe there's a follow-up or positive sentiment. But the user's instructions say to evaluate each news event's relevance. The 510(k) is relevant and positive. The short interest drop is also positive. However, the stock movement is intraday, so the most recent news would be the September 23 article, but it's a comparison article without specific positive info. Hmm. The 510(k) clearance is a solid reason. The drop in short interest by 19.6% is another factor. But the 10.23% increase is significant. Maybe the combination of these two factors? Or perhaps the 510(k) approval is the main driver. Let me check if there's any news closer to the trading period. The Head-To-Head article is on the 23rd, but the summary doesn't specify positive news. Given the information, the most relevant positive news is the 510(k) clearance for the new platform on September 14. That's a major event for a medical device company. The drop in short interest on the 16th is also positive. But since the stock moved intraday on the 23rd, the 510(k) might be the primary catalyst. Alternatively, maybe the short interest drop is the main driver. Wait, short interest decreasing by 19.6% is a significant positive sign. When short interest drops, it can indicate that short sellers are covering their positions, leading to upward pressure on the stock price. If the stock's intraday move happened after this news, that could explain the 10% jump. However, the 510(k) clearance is a more concrete business development. But the user's example shows that the relevant news is the one directly linked to the company's action. The 510(k) approval is a product-related milestone, which is a strong positive. The short interest drop is more about market sentiment. Which one is more likely to cause a 10% jump? Typically, product approvals can lead to significant price movements, especially in smaller companies. Given that, I think the key news is the 510(k) clearance for the Venus Versa Pro system. So the summary would link the intraday increase to this regulatory approval. The short interest drop is also positive but might be a secondary.